Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

July 5, 2025

Study Completion Date

December 31, 2025

Conditions

Haploidentical Hematopoietic Stem Cell Transplantation

Interventions

DRUG

ATG-LDPTCy

antithymocyte globulin with low dose post-transplant cyclophosphamide

Trial Locations (1)

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER